TLRC Director:

Kauczor HU 100x117web

Prof. Dr. Hans-Ulrich Kauczor

Universitätsklinikum Heidelberg (Heidelberg University Hospital)
Im Neuenheimer Feld 110
69120 Heidelberg, Germany

Tel.: +49 (0)6221-56 6410        Fax: +49 (0)6221-56 5730
E-Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

  • Medical Director, Department of Diagnostic and Interventional Radiology
  • Director of the Translational Lung Research Center Heidelberg (TLRC)
  • Acting Director, Dept. of Translational Pulmonology, Heidelberg University Hospital

TLRC Manager:

Dr. Birgit Teucher

Translational Lung Research Center (TLRC), Dept. of Translational Pulmonology, Heidelberg University Hospital, Universität Heidelberg, Im Neuenheimer Feld 156, 69120 Heidelberg

Tel.: +49 (0)6221-56 4296        Fax: +49 (0)6221-56 4504
E-Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

TLRC Partner Institutions

TLRC Research Profile

The Heidelberg Translational Lung Research Center (TLRC) is an interdisciplinary center for translational lung re- search in which physicians and scientists at the University Hospital and Medical Faculty of the University of Heidel- berg, the Thorax Clinic at the University Hospital (one of Germany’s largest hospitals specialized on lung diseases), the German Center for Cancer Research, and the European Molecular Biology Laboratory work together to combat lung disease. Our common goal is to improve diagnosis and therapy of chronic lung diseases in children and adults by promoting the close collaboration and exchange of expertise between basic research and clinical science.

The research focus is on elucidating the mechanisms underlying common genetic and acquired chronic and malignant lung diseases such as cystic fibrosis, COPD, and lung cancer. The scientists’ goal is to identify new therapeutic targets to improve early diagnosis and develop more curative treatment options. Within the basic research program cell- and animal models are used to investigate molecular causes of chronic airway diseases with a focus on the role of the airway epithelium. We make use of next generation-sequencing, as well as state-of-the-art immunology and molecular biology techniques. Results from these experiments will improve our understanding of airway mucous obstruction and chronic inflammation in cystic fibrosis and other chronic obstructive lung diseases, such as COPD and asthma. Systems biology is applied to improve our understanding of the molecular causes of lung cancer. Early clinical trials are conducted to make new diagnostic and therapeutic strategies available to patients in a timely manner.

Further information: